Items where Author is "Stern, M."

2016

Tschan-Plessl, A. and Stern, M. and Schmied, L. and Retiere, C. and Hirsch, H. H. and Garzoni, C. and van Delden, C. and Boggian, K. and Mueller, N. J. and Berger, C. and Villard, J. and Manuel, O. and Meylan, P. and Terszowski, G.. (2016) Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro. Transplant Direct, 2 (7). e89.

2015

Manuel, O. and Wojtowicz, A. and Bibert, S. and Mueller, N. J. and van Delden, C. and Hirsch, H. H. and Steiger, J. and Stern, M. and Egli, A. and Garzoni, C. and Binet, I. and Weisser, M. and Berger, C. and Cusini, A. and Meylan, P. and Pascual, M. and Bochud, P. Y. and Swiss Transplant Cohort, Study. (2015) Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation. The Journal of Infectious Diseases, 211 (6). pp. 906-914.

Hönger, G. and Krähenbühl, N. and Dimeloe, S. and Stern, M. and Schaub, S. and Hess, C.. (2015) Inter-individual differences in HLA expression can impact the CDC crossmatch. Tissue Antigens, 85 (4). pp. 260-266.

2014

Czaja, K. and Borer, A.-S. and Schmied, L. and Terszowski, G. and Stern, M. and Gonzalez, A.. (2014) A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs. Genes and immunity, Vol. 15, H. 1. pp. 33-37.

2013

Durovic, B. and Gasser, O. and Gubser, P. and Sigle, J. and Hirsch, H. H. and Stern, M. and Buser, A. and Hess, C.. (2013) Epstein-Barr virus negativity among individuals older than 60 years is associated with HLA-C and HLA-Bw4 variants and tonsillectomy. Journal of virology, Vol. 87, H. 11. pp. 6526-6529.

Charoudeh, H. N. and Terszowski, G. and Czaja, K. and Gonzalez, A. and Schmitter, K. and Stern, M.. (2013) Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. European journal of immunology, Vol. 43, H. 2. pp. 480-487.

Jankovicova, B. and Skultety, L. and Dubrovcakova, M. and Stern, M. and Bilkova, Z. and Lakota, J.. (2013) Overlap of epitopes recognized by anti-carbonic anhydrase I IgG in patients with malignancy-related aplastic anemia-like syndrome and in patients with aplastic anemia. Immunology letters, Vol. 153, No. 1-2. pp. 47-49.

Stern, M. and Passweg, J. R. and Meyer-Monard, S. and Esser, R. and Tonn, T. and Soerensen, J. and Paulussen, M. and Gratwohl, A. and Klingebiel, T. and Bader, P. and Tichelli, A. and Schwabe, D. and Koehl, U.. (2013) Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT : a prospective phase II study in two centers. Bone marrow transplantation, Vol. 48, H. 3. pp. 433-438.

2012

Lakota, J. and Lanz, A. and Dubrovcakova, M. and Jankovicova, B. and Gonzalez, A. and Stern, M.. (2012) Antibodies against carbonic anhydrase in patients with aplastic anemia. Acta Haematologica, 128 (3). pp. 190-194.

Stern, M. and Czaja, K. and Rauch, A. and Rickenbach, M. and Gunthard, H. F. and Battegay, M. and Fellay, J. and Hirschel, B. and Hess, C. and Swiss, H. I. V. Cohort Study Group. (2012) HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruption. HIV medicine, Vol. 13, H. 10. pp. 589-595.

Egli, A. and Bucher, C. and Dumoulin, A. and Stern, M. and Buser, A. and Bubendorf, L. and Gregor, M. and Servida, P. and Sommer, G. and Bremerich, J. and Gratwohl, A. and Khanna, N. and Widmer, A. F. and Battegay, M. and Tamm, M. and Hirsch, H. H. and Halter, J. P.. (2012) Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection, 40 (6). pp. 677-684.

Terszowski, G. and Passweg, J. R. and Stern, M.. (2012) Natural killer cell immunity after transplantation. Swiss medical weekly, Vol. 142 , w13700.

Charoudeh, H. N. and Schmied, L. and Gonzalez, A. and Terszowski, G. and Czaja, K. and Schmitter, K. and Infanti, L. and Buser, A. and Stern, M.. (2012) Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells. Immunogenetics, Vol. 64, H. 10. pp. 739-745.

2011

Gerull, S. and Arber, C. and Bucher, C. and Buser, A. and Gratwohl, A. and Halter, J. and Heim, D. and Tichelli, A. and Stern, M.. (2011) Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT. Bone marrow transplantation, Vol. 46, H. 5. pp. 740-746.

Arber, C. and Halter, J. and Stern, M. and Rovó, A. and Gratwohl, A. and Tichelli, A.. (2011) Graft source determines human hematopoietic progenitor distribution pattern within the CD34(+) compartment. Bone marrow transplantation, Vol. 46, H. 5. pp. 650-658.

O'Meara, A. and Pabst, T. and Heim, D. and Gerull, S. and Bucher, C. and Halter, J. and Arber, C. and Rovò, A. and Tichelli, A. and Gratwohl, A. and Stern, M.. (2011) High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML. Bone marrow transplantation, Vol. 46, H. 5. pp. 636-640.

Conen, A. and Weisser, M. and Hohler, D. and Frei, R. and Stern, M.. (2011) Hormographiella aspergillata : an emerging mould in acute leukaemia patients? Clinical microbiology and infection, Vol. 17, H. 2. pp. 273-277.

Bühlmann, L. and Buser, A. S. and Cantoni, N. and Gerull, S. and Tichelli, A. and Gratwohl, A. and Stern, M.. (2011) Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT. Bone marrow transplantation, Vol. 46, H. 10. pp. 1357-1362.

Cantoni, N. and Gerull, S. and Heim, D. and Halter, J. and Bucher, C. and Buser, A. and Tsakiris, D. A. and Passweg, J. and Tichelli, A. and Stern, M. and Gratwohl, A.. (2011) Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone marrow transplantation, Vol. 46, H. 3. pp. 344-349.

Stern, M. and Hadaya, K. and Honger, G. and Martin, P. Y. and Steiger, J. and Hess, C. and Villard, J.. (2011) Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation. American journal of transplantation, Vol. 11, H. 6. pp. 1302-1307.

Jeger, A. and Favre, G. and Lutz, J.-M. and Stern, M. and Usel, M. and Rovo, A. and Rischewski, J. and Tichelli, A. and Gratwohl, A. and Halter, J.. (2011) Tumor incidence in related hematopoietic stem cell donors. Bone marrow transplantation, Vol. 46, H. 9. pp. 1240-1244.

2010

Stern, M. and de Angelis, C. and Urbani, E. and Mancusi, A. and Aversa, F. and Velardi, A. and Ruggeri, L.. (2010) Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. Bone marrow transplantation, Vol. 45, H. 11. pp. 1607-1610.

2009

Zenhaeusern, G. and Gasser, O. and Hönger, G. and Durovic, B. and Stern, M. and Hess, C.. (2009) Regulatory allospecific NK cell function is differentially associated with HLA C allotypes. American journal of transplantation : official journal of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST), Vol. 9. pp. 2624-2630.

2008

Stern, M. and Brand, R. and de Witte, T. and Sureda, A. and Rocha, V. and Passweg, J. and Baldomero, H. and Niederwieser, D. and Gratwohl, A.. (2008) Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. American journal of transplantation, Vol. 8. pp. 2149-2157.

Gratwohl, A. and Döhler, B. and Stern, M. and Opelz, G.. (2008) H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet, Vol. 372. pp. 49-53.

Birrer, A. and Jusufi, F. and Bernimoulin, M. and Tichelli, A. and Gratwohl, A. and Nissen-Druey, C. and Dirnhofer, S. and Meyer-Monard, S. and Stern, M.. (2008) Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis. European journal of haematology, Vol. 81, H. 4. pp. 267-272.

Buser, A. and Stern, M. and Arber, C. and Medinger, M. and Halter, J. and Rovo, A. and Favre, G. and Lohri, A. and Tichelli, A. and Gratwohl, A.. (2008) Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab? Bone Marrow Transplantation, 42 (7). pp. 483-487.

Stern, M. and Halter, J. and Buser, A. and Rovò, A. and Dirnhofer, S. and Häusermann, P.. (2008) Leukemia cutis preceding systemic relapse of acute myeloid leukemia. International journal of hematology, Vol. 87, H. 2. pp. 108-109.

Bernimoulin, M. and Stern, M. and Tichelli, A. and Jotterand, M. and Gratwohl, A. and Nissen, C.. (2008) Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome. Acta Haematologica, 119 (4). pp. 226-235.

Stern, M. and Paulussen, M. and Rischewski, J. and Tichelli, A. and Gratwohl, A.. (2008) Missing ligand model in autologous stem cell transplantation. British journal of cancer, Vol. 98, no. 4. pp. 852-853.

Rovó, A. and Daikeler, T. and Stern, M. and Halter, J. and Studt, J. D. and Buser, A. and Heim, D. and Rischewski, J. and Medinger, M. and Tyndall, A. and Gratwohl, A. and Tichelli, A.. (2008) Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood, 111. pp. 1740-1741.

Stern, M. and Elsässer, H. and Hönger, G. and Steiger, J. and Schaub, S. and Hess, C.. (2008) The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. American journal of transplantation, Vol. 8. pp. 1312-1317.